William B. White

32.5k total citations · 12 hit papers
440 papers, 21.7k citations indexed

About

William B. White is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, William B. White has authored 440 papers receiving a total of 21.7k indexed citations (citations by other indexed papers that have themselves been cited), including 267 papers in Cardiology and Cardiovascular Medicine, 122 papers in Endocrinology, Diabetes and Metabolism and 85 papers in Surgery. Recurrent topics in William B. White's work include Blood Pressure and Hypertension Studies (202 papers), Hormonal Regulation and Hypertension (74 papers) and Heart Rate Variability and Autonomic Control (72 papers). William B. White is often cited by papers focused on Blood Pressure and Hypertension Studies (202 papers), Hormonal Regulation and Hypertension (74 papers) and Heart Rate Variability and Autonomic Control (72 papers). William B. White collaborates with scholars based in United States, United Kingdom and France. William B. White's co-authors include William C. Cushman, George L. Bakris, David A. Calhoun, Robert M. Carey, Stuart Kupfer, Domenic Sica, Christopher P. Cannon, Faı̈ez Zannad, Cyrus R. Mehta and Stephen C. Textor and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

William B. White

423 papers receiving 20.8k citations

Hit Papers

Alogliptin aft... 1958 2026 1980 2003 2013 2008 2008 2019 1991 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
    2013 1.9k citations William B. White, Christopher P. Cannon et al. New England Journal of Medicine profile →
  2. Resistant Hypertension: Diagnosis, Evaluation, and Treatment
    2008 1.7k citations William C. Cushman, William B. White et al. Circulation profile →
  3. Resistant Hypertension: Diagnosis, Evaluation, and Treatment
    2008 1.0k citations William C. Cushman, William B. White et al. Hypertension profile →
  4. Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association
    2019 867 citations William B. White et al. Hypertension profile →
  5. Hypertension: Pathophysiology, Diagnosis, and Management
    1991 732 citations William B. White profile →
  6. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
    2018 655 citations George L. Bakris, William B. White et al. Hypertension profile →
  7. Chemical Equilibrium in Complex Mixtures
    1958 647 citations William B. White et al. profile →
  8. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    2018 578 citations William B. White, Kenneth G. Saag et al. New England Journal of Medicine profile →
  9. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
    2015 551 citations Faı̈ez Zannad, Christopher P. Cannon et al. profile →
  10. Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
    2011 380 citations William B. White, Michael A. Becker et al. profile →
  11. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: A systematic review and meta-analysis
    2014 358 citations William B. White et al. profile →
  12. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
    2019 215 citations Rajiv Agarwal, Patrick Rossignol et al. profile →

Peers

William B. White
Franz H. Messerli United States
Roland E. Schmieder Germany
Robert M. Carey United States
Sadayoshi Ito Japan
Luís M. Ruilope Spain
Guıdo Grassı Italy
Henry Krum Australia
Anna F. Dominiczak United Kingdom
Nancy J. Brown United States
Norman K. Hollenberg United States
Franz H. Messerli United States
William B. White
Citations per year, relative to William B. White William B. White (= 1×) peers Franz H. Messerli

Countries citing papers authored by William B. White

Since Specialization
Citations

This map shows the geographic impact of William B. White's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William B. White with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William B. White more than expected).

Fields of papers citing papers by William B. White

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William B. White. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William B. White. The network helps show where William B. White may publish in the future.

Co-authorship network of co-authors of William B. White

This figure shows the co-authorship network connecting the top 25 collaborators of William B. White. A scholar is included among the top collaborators of William B. White based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William B. White. William B. White is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saag, Kenneth G., Nicola Dalbeth, Chang‐Fu Kuo, et al.. (2025). Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies. Contemporary Clinical Trials. 151. 107843–107843.
2.
3.
Ben‐Joseph, Rami, Virend K. Somers, Jed Black, et al.. (2024). Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study. Mayo Clinic Proceedings. 99(11). 1710–1721. 5 indexed citations
4.
Bruce, Ian N, Ronald van Vollenhoven, Eric F. Morand, et al.. (2022). Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: apost hocanalysis of the TULIP-1 and TULIP-2 trials. Lara D. Veeken. 62(4). 1526–1534. 20 indexed citations
5.
6.
Ferreira, João Pedro, Patrick Rossignol, George L. Bakris, et al.. (2021). Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial. American Journal of Nephrology. 52(12). 969–976. 3 indexed citations
7.
White, William B., Adrian S. Dobs, Culley C. Carson, et al.. (2021). Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. Journal of Cardiovascular Pharmacology and Therapeutics. 26(6). 630–637. 18 indexed citations
8.
Agarwal, Rajiv, Patrick Rossignol, Susan Arthur, et al.. (2020). Patiromer to Enable Spironolactone in Patients with Resistant Hyperten-sion and CKD (AMBER): Results in the Prespecified Subgroup with Diabetes. Journal of the American Society of Nephrology. 31(10S). 36–36. 1 indexed citations
9.
Swerdloff, Ronald S., Christina Wang, William B. White, et al.. (2020). A New Oral Testosterone Undecanoate Formulation Restores Testosterone to Normal Concentrations in Hypogonadal Men. The Journal of Clinical Endocrinology & Metabolism. 105(8). 2515–2531. 61 indexed citations
10.
White, William B., Dorothy Wakefield, Nicola Moscufo, et al.. (2019). Effects of Intensive Versus Standard Ambulatory Blood Pressure Control on Cerebrovascular Outcomes in Older People (INFINITY). Circulation. 140(20). 1626–1635. 81 indexed citations
11.
White, William B., Christopher R. Chapple, Christian Gratzke, et al.. (2018). Cardiovascular Safety of the β3‐Adrenoceptor Agonist Mirabegron and the Antimuscarinic Agent Solifenacin in the SYNERGY Trial. The Journal of Clinical Pharmacology. 58(8). 1084–1091. 17 indexed citations
12.
White, William B., Peter R. Kowey, Ulysses Diva, Mark Sostek, & Raj Tummala. (2018). Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation. Journal of Cardiovascular Pharmacology and Therapeutics. 23(4). 309–317. 10 indexed citations
13.
White, William B., Kenneth G. Saag, Michael A. Becker, et al.. (2018). Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. New England Journal of Medicine. 378(13). 1200–1210. 578 indexed citations breakdown →
14.
White, William B., et al.. (2018). Alogliptin in Patients with Type 2 Diabetes Receiving Metformin and Sulfonylurea Therapies in the EXAMINE Trial. The American Journal of Medicine. 131(7). 813–819.e5. 16 indexed citations
15.
White, William B., Robert A. Kloner, Dominick J. Angiolillo, & Michael H. Davidson. (2018). Cardiorenal Safety of OTC Analgesics. Journal of Cardiovascular Pharmacology and Therapeutics. 23(2). 103–118. 21 indexed citations
16.
Ferdinand, Keith C., George L. Bakris, William C. Cushman, et al.. (2018). Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. The American Journal of Cardiology. 122(9). 1496–1505. 4 indexed citations
17.
18.
White, William B., Vladimir Hanes, Vijay S. Chauhan, & Bertram Pitt. (2006). Effects of a New Hormone Therapy, Drospirenone and 17-β-Estradiol, in Postmenopausal Women With Hypertension. Hypertension. 48(2). 246–253. 83 indexed citations
19.
Simon, Lee S. & William B. White. (2005). COX-2 selective inhibitors and heart health.. PubMed. 117(1 Suppl). 7–20. 3 indexed citations
20.
White, William B.. (2001). Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Humana Press eBooks. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz H. Messerli Breakdown of academic impact, for papers by Roland E. Schmieder Breakdown of academic impact, for papers by Robert M. Carey Breakdown of academic impact, for papers by Sadayoshi Ito Breakdown of academic impact, for papers by Luís M. Ruilope Breakdown of academic impact, for papers by Guıdo Grassı Breakdown of academic impact, for papers by Henry Krum Breakdown of academic impact, for papers by Anna F. Dominiczak Breakdown of academic impact, for papers by Nancy J. Brown Breakdown of academic impact, for papers by Norman K. Hollenberg
Rankless by CCL
2026